Multiparametric assay to screen and dissect the mode of action of anti-human immunodeficiency virus envelope drugs
- PMID: 16127073
- PMCID: PMC1195414
- DOI: 10.1128/AAC.49.9.3926-3929.2005
Multiparametric assay to screen and dissect the mode of action of anti-human immunodeficiency virus envelope drugs
Abstract
A flow cytometry-based assay was used to simultaneously quantify X4 and R5 human immunodeficiency virus (HIV) envelope-mediated cell-to-cell viral transfer, cell death, and cell-to-cell fusion. In this assay, different anti-HIV envelope drugs showed characteristic inhibitory profiles for each measured parameter, allowing for the rapid identification of the mode of action of active compounds.
Figures
References
-
- Armand-Ugon, M., A. Gutierrez, B. Clotet, and J. A. Este. 2003. HIV-1 resistance to the gp41-dependent fusion inhibitor C-34. Antivir. Res. 59:137-142. - PubMed
-
- Baba, M., O. Nishimura, N. Kanzaki, M. Okamoto, H. Sawada, Y. Iizawa, M. Shiraishi, Y. Aramaki, K. Okonogi, Y. Ogawa, K. Meguro, and M. Fujino. 1999. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. USA 96:5698-5703. - PMC - PubMed
-
- Barretina, J., J. Blanco, M. Armand-Ugón, A. Gutiérrez, B. Clotet, and J. A. Esté. 2003. Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death. Antivir. Ther. 8:155-161. - PubMed
-
- Barretina, J., J. Blanco, A. Bonjoch, A. Llano, B. Clotet, and J. A. Este. 2004. Immunological and virological study of enfuvirtide-treated HIV-positive patients. AIDS 18:1673-1682. - PubMed
-
- Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
